Oncology Data Advisor

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 95:51:39
  • More information

Informações:

Synopsis

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Episodes

  • Developing a TNBC Polygenic Risk Score for Black Women: Holly Pederson, MD, and Elisha Hughes, PhD

    20/06/2024 Duration: 12min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Predicting Immunotherapy Benefit in Lung Cancer and Beyond: Ofer Sharon, MD

    20/06/2024 Duration: 12min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Highlights of Brain Tumor and CNS Research at ASCO: Morana Vojnic, MD, MBA

    20/06/2024 Duration: 07min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Advocates for Universal DPD/DPYD Testing: Karen Merritt and Dan Hertz, PharmD, PhD

    20/06/2024 Duration: 09min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Exploring the Tumor Microenvironment of Invasive Lobular Carcinoma: Jason Mouabbi, MD

    20/06/2024 Duration: 16min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Effective Care for Substance Use Disorders in Cancer, APN Perspective: Gretchen McNally, APRN-CRP

    20/06/2024 Duration: 07min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • A Sneak Peek Into Von Hippel-Lindau Disease Treatment Advances: Eric Jonasch, MD

    20/06/2024 Duration: 05min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • Count Me In - Partnering With Patients to Accelerate the Pace of Cancer Research: Melissa Mirick

    19/06/2024 Duration: 05min

    This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

  • An Innovative Wellness and Professional Development Curriculum for Fellows: Thejal Srikumar, MD

    13/06/2024 Duration: 10min

    An Innovative Wellness and Professional Development Curriculum for Fellows: Thejal Srikumar, MD by i3 Health

  • Implementing a Novel Research Methods Training Curriculum for Fellows: Noha Sharafeldin, MD, PhD, and Waqas Haque, MD

    13/06/2024 Duration: 10min

    Implementing a Novel Research Methods Training Curriculum for Fellows: Noha Sharafeldin, MD, PhD, and Waqas Haque, MD by i3 Health

  • Understanding Cardiovascular Risks of BTK Inhibitors in Hematologic Malignancies: Muhammad Salman Faisal, MBBS

    13/06/2024 Duration: 03min

    Understanding Cardiovascular Risks of BTK Inhibitors in Hematologic Malignancies: Muhammad Salman Faisal, MBBS by i3 Health

  • The Fellow on Call and Fellowship Research at ASCO: Ronak Mistry, DO, and Vivek Patel, MD

    13/06/2024 Duration: 13min

    The Fellow on Call and Fellowship Research at ASCO: Ronak Mistry, DO, and Vivek Patel, MD by i3 Health

  • Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS

    13/06/2024 Duration: 05min

    Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS by i3 Health

  • Artful Oncology - A Psychosocial Oncology Curriculum for Heme/Onc Fellows: Jafar Al-Mondhiry, MD

    13/06/2024 Duration: 16min

    Artful Oncology - A Psychosocial Oncology Curriculum for Heme/Onc Fellows: Jafar Al-Mondhiry, MD by i3 Health

  • The Sarcoma Foundation of America: Brandi Felser and Waqas Haque, MD, MPH

    13/06/2024 Duration: 18min

    The Sarcoma Foundation of America: Brandi Felser and Waqas Haque, MD, MPH by i3 Health

  • The Fellows Forum Live from ASCO 2024: Samuel Kareff, MD, Waqas Haque, MD, and Matthew Hadfield, DO

    13/06/2024 Duration: 13min

    The Fellows Forum Live from ASCO 2024: Samuel Kareff, MD, Waqas Haque, MD, and Matthew Hadfield, DO by i3 Health

  • Piloting Palliative Care Education for Fellows: Jessica Bauman, MD

    13/06/2024 Duration: 15min

    Piloting Palliative Care Education for Fellows: Jessica Bauman, MD by i3 Health

  • Representing Fellows in Evidence-Based Wellness Interventions: Andrew Hearn, MD, MSCI

    13/06/2024 Duration: 06min

    Representing Fellows in Evidence-Based Wellness Interventions: Andrew Hearn, MD, MSCI by i3 Health

  • Cold Agglutinin Disease: Answers to Frequently Asked Questions With Catherine Broome, MD

    12/06/2024 Duration: 04min

    In this video, Dr. Catherine M. Broome, Professor of Medicine at Georgetown University Medical Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Putting the Freeze on Cold Agglutinin Disease (CAD). Dr. Broome shares insights into resources she recommends for patients with CAD, the role of thromboprophylaxis, treatment advances to expect within the next year, the most important things for primary care providers and non-hematologists to know about CAD, and more! Interested in completing this activity and earning FREE CME/NCPD credit? Click here: https://bit.ly/3RlJJ8X

  • Early-Stage Non–Small Cell Lung Cancer: Answers to Frequently Asked Questions

    07/06/2024 Duration: 05min

    In this video, Dr. Jamie E. Chaft, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Leveraging the Growing Arsenal of Therapies for Early-Stage Non–Small Cell Lung Cancer (NSCLC), chaired by Dr. Helena Yu. Dr. Chaft shares insights into emerging roles of measurable residual disease (MRD) in lung cancer, the significance of the recent approval of alectinib for ALK-positive disease, treatment considerations for older versus younger patients, important research updates at the American Society of Clinical Oncology (ASCO) Annual Meeting, and more!

page 4 from 21